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Background: Escherichia coliOmpA interacts with FcRI -chain (FcRIa) to invade macrophages.
Results: Lack of three N-glycans in FcRIa prevents E. coli invasion of macrophages and the onset of meningitis.
Conclusion:OmpA binding to FcRIa via N-glycans is crucial in the pathogenesis of E. colimeningitis.
Significance: Targeting OmpA and FcRIa interface may be a therapy for E. coli-induced meningitis.
Neonatal meningitis, caused by Escherichia coli K1, is a seri-
ous central nervous system disease. We have established that
macrophages serve as permissive niches for E. coli K1 to multi-
ply in the host and for attaining a threshold level of bacterial
load,which is a prerequisite for the onset of thedisease.Here,we
demonstrate experimentally that three N-glycans in FcRIa
interact withOmpAof E. coliK1 for binding to and entering the
macrophages.Adoptive transfer of FcRIa/bonemarrow-de-
rived macrophages transfected with FcRIa into FcRIa/
newborn mice renders them susceptible to E. coli K1-induced
meningitis. In contrast, mice that received bone marrow-de-
rivedmacrophages transfected with FcRIa in whichN-glycosyla-
tion sites 1, 4, and 5 are mutated to alanines exhibit resistance to
E. coliK1 infection.Ourmolecular dynamics and simulation stud-
ies predict thatN-glycan 5 exhibits strongbinding at the barrel site
ofOmpAformedby loops3and4,whereasN-glycans1and4 inter-
act with loops 1, 3, and 4 of OmpA at tip regions. Molecular mod-
eling data also suggest no role for the IgG binding site in the inva-
sionprocess. Inagreement, experimentalmutations in IgGbinding
site had no effect on the E. coliK1 entry intomacrophages in vitro
or on the onset ofmeningitis in newbornmice. Together, this inte-
grationof experimental andcomputational studies revealshowthe
N-glycans in FcRIa interact with the OmpA of E. coli K1 for
inducing the disease pathogenesis.
In the event of bacterial invasion of host tissues, the intruder
encounters an arsenal of host defensemechanisms that result in
either resolution of the pathogen by the host or subversion of
the defense by the pathogen. Cross-talk between host defense
components is critical for successful resolution of the infection.
Macrophages are long-lived cells that play a critical role in
engulfing pathogenic microorganisms and degrading them.
They express a range of receptors that recognize bacteria, includ-
ing Toll-like receptors, Fc receptors, complement receptors,
scavenger receptors, and mannose receptors (1, 2). Most micro-
bial structures are recognized by more than one macrophage
receptor, and these receptors also interact with each other. Sev-
eral pathogens subvert the antimicrobial mechanism by
exploiting receptor interactions to create their own safe havens
inside of which they survive. The bacterial pathogens upon
entering the host are coated with complement proteins, en-
abling them to be recognized by complement receptors on the
macrophages (3). Similarly, antibody-coated bacterial recogni-
tion involves interaction with Fc receptors, which subse-
quently elicits antimicrobial mechanisms. A large number of
bacteria introduce microbial factors that govern macrophage
function by type III or IV secretion systems (1). However, very
few bacteria control the attack of macrophages at the receptor
level. One example is Staphylococcus aureus, which uses pro-
tein A to bind to the Fc region of IgG, thus avoiding recognition
by Fc receptors (4).
Several studies have shown that FcRI expression increases
during septicemia and meningitis caused by a variety of bacte-
ria. The Fc region of IgG recognizes Fc receptors (FcRs),4
enabling it to play an important role in linking the cellular and
humoral immune response. FcR comprises amultigene family
divided into three classes (FcRI, II, and III), which are defined
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by their affinity for IgG. FcRI is a transmembrane receptor
that binds IgG with high affinity and induces the association of
the -chain for signal transduction and triggering of effector
responses such as macrophage phagocytosis. The ligation of
FcRI with IgG also mediates antibody-dependent cellular
cytotoxicity-induced transcription of cytokine genes and
release of inflammatory mediators (5). We previously demon-
strated that OmpA (outer membrane protein A) of Escherichia
coli K1, which causes neonatal meningitis, directly interacts
with Fc receptor I -chain (FcRIa) to bind to and enter
macrophages. Indeed, depletion of macrophages or lack of
FcRIa expression in macrophages in newborn mice renders
the animals resistant to E. coli K1-induced meningitis. Despite
the general requirement of FcRIa association with the -chain
for the internalization of the receptor, the interaction of
OmpA E. coli with FcRIa and the subsequent entry into
macrophages do not require the -chain to facilitate E. coli K1
entry intomacrophages, which is a novel mechanism. E. coliK1
interaction withmacrophages in the absence of FcRIa induces
the expression of complement receptor 3, which elicits antimi-
crobialmechanisms to kill the intracellular bacteria (6). In addi-
tion, macrophages generate biopterin and neopterin upon
E. coli K1 infection to suppress the production of nitric oxide
and superoxide, respectively (7). We showed previously that
mutation of three amino acids in loops 1 and 3 of the extracel-
lular domains of OmpA prevented the bacterial survival in
macrophages. Concomitantly, E. coli K1 containing a mutation
in loop 1 could not cause meningitis in newborn mouse model
(8). However, there has been no molecular level understanding
of how OmpA interaction with FcRIa controls these cellular
events.
OmpA has been shown to interact with GlcNAc1–4GlcNAc
epitopes of host receptors (9, 10). In addition, our previous
molecular modeling predictions of OmpA interaction with
GlcNAc1–4GlcNAc epitopes demonstrated that this moiety
can bind to OmpA at two sites, one at the tip of loops 1 and 2
and the second at the barrel site formed by loops 3 and 4 (6).We
now report investigations on the role ofN-glycans in FcRIa in
E. coli K1 entry of macrophages and for the onset of meningitis
in the newborn mouse model. The experimental studies show
that N-glycosylation sites 1, 4, and 5 of FcRIa are critical for
interacting with OmpA of E. coli K1, both for binding to and
entry of macrophages. Adoptive transfer of FcRIa/macro-
phages transfected with N-glycosylation (NG) mutants of
FcRIa into FcRIa/ mice revealed that the presence of
FcRIa with one, four, or five NG sites are important for the
onset of meningitis. To determine a structural basis for the
experimental results, we conducted computer simulations to
predict the atomistic structure for the OmpA protein com-
plexed with the glycosylated FcRIa, which identified how
N-glycans contribute to the E. coli K1 interaction with
macrophages.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Antibodies, and Other Reagents—Esche-
richia coli K1 (OmpA E. coli) is a spontaneous rifampicin-
resistant mutant of strain RS218 (serotype O18:K1:H7), which
was isolated from the cerebrospinal fluid of a newborn with
meningitis (12). Bacteria were grown in LB medium (Difco,
Detroit, MI) with 100 g/ml rifampicin. Antibodies to FcRIa
and Myc tag were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA) and Cell Signaling Technology (Danvers,
MA), respectively. Secondary antibodies tagged to various fluo-
rophores were purchased from Invitrogen. FuGENE HD re-
agent from Roche Applied Science was used for plasmid trans-
fection. QuikChange site-directed mutagenesis kit was from
Agilent Technologies (Santa Clara, CA). Phagocytosis assay kit
(IgG-FITC) was from Cayman chemical company (Ann Arbor,
MI).
E. coli Invasion Assays—Bone marrow-derived macrophages
(BMDMs) were isolated and cultured as described earlier (6).
RAW 264.7 macrophages were grown to confluence (105
cells/well) in 24-well plates. RAW 264.7 macrophages were
then incubated with 106 colony forming units (CFU) of E. coli
K1 in experimental medium (DMEM containing 5% heat-inac-
tivated fetal bovine serum) for 60 min at 37 °C in CO2 incuba-
tor. For BMDMs, the cells were incubated for 2 h with 106 CFU
of E. coli K1. The monolayers were washed three times with
RPMI 1640 and incubated further with experimental medium
containing gentamicin (100 g/ml) for 1 h to kill bound bacte-
ria. The monolayers were washed again and lysed with 0.5%
Triton X-100. The intracellular bacteria were determined by
plating the dilutions on sheep blood agar. To enumerate the
total cell-associated bacteria, the experiments were performed
without a gentamicin step.
Western Blotting—RAW 264.7 or BMDMs (WT and FcRIa/)
were transfected with FL-FcRIa or NG-FcRIa mutants using
FuGENE HD according to the manufacturer’s instructions and
allowed to recover for 24 h, and the total cell lysates were pre-
pared using lysis buffer (50 mM Tris-Cl, 150 mM NaCl, 1 mM
EGTA, and 1% Triton X-100). Unbroken cells and cell debris
were removed by centrifuging the lysates at 700 g for 10 min
at 4 °C. The protein content was estimated using Pierce BCA
protein assay kit. 40g of protein fractions were resolved on an
8% gel and transferred to a nitrocellulose membrane. The
membranewas blockedwith 5%milk in PBS, 0.1%Tween 20 for
1 h at room temperature. The blots were then incubated with
anti-Myc or anti-FcRIa antibodies overnight using appropri-
ate dilutions and counterstainedwithHRP-conjugated second-
ary antibody. The membrane was developed with Super Signal
chemiluminescence substrate (Pierce) and exposed to x-ray
film for protein visualization.
Flow Cytometry—To detect the expression of transfected
FcRIa plasmids using Myc antibody, RAW 264.7 or BMDMs
(WT and FcRIa/) were transfected as described earlier and
allowed to recover for 24 h. The cells were washed three times
with PBS and then detached with TrypLE Express (Invitrogen)
from the plates. The cells were fixed using BD Cytofix for 15
min, washed, and preincubated for 30 min with blocking/wash
buffer (PBS  3% normal goat serum) to mask nonspecific
binding sites. Cells were then incubated with anti-Myc anti-
body or an isotype-matched control antibody for 1 h at 4 °C and
washed with buffer. Then FITC-conjugated secondary anti-
body was added, incubated for 30 min at 4 °C, and washed with
the buffer. The stained cells were then analyzed by four-color
flow cytometry using FACSCalibur Cell Quest Pro software
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(BD Biosciences, San Diego, CA), and at least 10,000 events
were collected for analysis. The results are expressed as bar
graphs or histogram overlays with respect to isotype-matched
antibody controls. For detection of IgG-FITC uptake, trans-
fected RAW 264.7 or BMDMs were incubated with 25 l of
IgG-FITC beads for 2 h at 37 °C to promote phagocytosis. The
extracellular fluorescence from noninternalized beads was
quenched with 500 l of trypan blue (diluted 1:10 in assay
buffer) and then subjected to processing for flow cytometry as
mentioned above. Alexa 647 secondary antibody was used to
detect Myc expression, and histogram overlays were plotted
using FL1 (FITC) and FL4 (Alexa 647) channels.
Transmission and Scanning Electron Microscopy—WT BMDMs
were transfected with FcRIa-FL or FcRIa-NG mutants and
incubated with E. coli K1 at a multiplicity of infection of 10 for
1 h, washed, and then fixed with 2% glutaraldehyde in 0.1 M
cacodylate buffer, pH 7.1. All samples were washed three times
in 0.1 M cacodylate buffer for 15 min each. The cells were then
postfixed for 20min in 1% osmium tetroxide at 4 °C followed by
addition of EtOH (60%). Samples were dehydrated through 70,
80, 95, and 100% EtOH (two times, 15 min each) and then into
propylene oxide (two time, 15 min each), and into a 1:1 propyl-
ene oxide/eponate, left overnight, and capped at room temper-
ature. The propylene oxide/eponate mixture was decanted and
replacedwith 100% eponatemixture. The samples were polym-
erized at 70 °C for 48 h. Thin sections (80 nm) were cut using a
diamond knife, mounted on uncoated 300 mesh copper grids
and stained with 5% uranyl acetate for 20 min. Photographs
were taken with transmission electron microscopy (JEOL JEM
2100 LaB6) or scanning electron microscopy (JEOL JSM/
6390LV).
Tissue Immunostaining—Sections of paraffinized brain sec-
tions from control and infected pups were submitted to the
Department of Pathology, Children’s Hospital Los Angeles for
hematoxylin and eosin (H&E), glial fibrillary acidic protein
(GFAP), and myeloperoxidase (MPO) staining.
Newborn Mouse Model of Meningitis—The animal studies
were approved by the Institutional Animal Care and Use Com-
mittee of Children’s Hospital of Los Angeles and followed
guidelines for the performance of animal experiments imple-
mented by the National Institutes of Health. FcRIa/ mice
were described previously (6). FcRIa/ BMDMs were cul-
tured in Petri dishes andmaintained till the pupswere born.On
the day of birth, the BMDMs were transferred to 24-well plates
and transfected with the respective FcRIa plasmids after 24 h.
Three-day-old mouse pups (n  5 per group) were infected
intranasally with 103 CFU of bacteria in pyrogen-free saline as
previously described (6). 5 l of facial vein blood was collected
aseptically from all the pups in the respective groups at 48 h
postinfection to determine the bacterial load by plating 10-fold
serial dilutions on rifampicin LB agar plates. All the pups were
euthanatized at 72 h postinfection, and cerebrospinal fluid was
collected from all the pups without traumatic trap and incu-
bated overnight in LB broth with rifampicin to check for bac-
terial growth. 5l of blood was collected by heart puncture and
plated on rifampicin LB agar plates after serial dilution. One
half of the brain from all the pups was homogenized, serial
diluted, and plated on rifampicin LB agar to determine brain
bacterial load. The other half of the brain was preserved in
formalin, paraffin-embedded, and sectioned for staining.
Protein-Protein Docking Protocol—Ahybrid docking strategy
was adopted that first considered an ensemble of 15 protein
conformations forOmpA.Next, each of the conformations was
docked to FcRIa to obtain an ensemble of 810,000 OmpA-
FcRIa protein-protein poses through exhaustive rotational
and translational sampling of the relative position space that
satisfies shape complementarity of the two given protein con-
formations. Then experimental observations and topological
constraints were used to dramatically reduce the most likely
poses to just a few that could be subjected to more detailed
considerations including molecular dynamics. This strategy
overcomes the limitations of finding scoring functions that can
reliably rank the energies for protein-protein interactions, and
it reduces the issues regarding the conformational flexibility of
glycosylated amino acids.
First, an ensemble of 15 structures of OmpA that consider
the flexibility of its four loops was predicted. To construct this
ensemble, (a) we selected as one candidate the PDB code
1BXWx-ray crystal structure ofOmpA,which resolvesmore of
the loop regions than the PDB code 1QJP x-ray crystal structure
(13, 14). (b) In addition, 2.5-ns MD simulation of the protein in
explicit membrane and water (including salt) was carried out,
starting from a conformation previously generated from the
1BXW x-ray crystal structure equilibrated with MD at 300 K.
Here the protein was embedded in a periodically infinite box
containing the POPC lipid system fully solvated with water and
salt. We used the CHARMM26 forcefield method for the lipid
andOmpAprotein and theTIP3Pwater forcefield (15–17). The
visual molecular dynamics membrane plug-in to build the
membrane and the visual molecular dynamics solvate plug-in
to solvate the protein at both the intracellular and extracellular
regions were used (18). All MD simulations used the NAMD
program (19) with the isothermal-isobaric ensemble and peri-
odic boundary conditions at 300 K and 1 atm. From this trajec-
tory, 2500 conformations (1 snapshot every 1 ps) have been
selected, which we clustered into 13 diverse structures using an
root mean square deviation Voronoi criterion of 1.5 Å, from
which we selected the 13 family heads. (c) In addition, an
ensemble of 10 candidate structures based on distance-geome-
try fits to NMR (PDB code 1G90) (20) is available, and their
energieswereminimized in vacuumusing theDREIDING force
field (21). From this, the one with the lowest total energy (num-
ber 4) was selected.
These 15 OmpA conformations have a minimum root mean
square deviation diversity of 1.5 Å in the loop regions. Next, we
examined the crystal structure of FcRIa (PDB code 3RJD) (22).
The interaction between theD1 andD2 fragments in the crystal
is well defined; however, the D3 fragment is interacting with a
nearby image of the protein in the crystal packing as visualized
in the crystal supercell. This interaction may cause artifacts in
the hinge angle between D2 and D3 fragments. Therefore, only
the Ig-like domains D1 and D2 of the FcRIa crystal structure
were taken for docking purposes. Then the Man-Man1-
4GlcNAc 1–4GlcNAc1 portion of N-glycans to each of the
five N-glycosylation sites on D1 and D2 (residues 59, 78, 152,
159, and 163, predicted by NetNGlyc 1.0 Server) was added.
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Further, we relaxed the backbone ofD1 andD2with 1-nsMD in
a solvent box of explicit water (including 154 mM NaCl or 0.9%
w/w NaCl), whereas the side chains including the N-glycans
were relaxed with 5 ns of MD in explicit water. The snapshot
closest to the average conformation was then chosen for
docking.
To describe the glycosylated Asn consistently with natural
amino acids in the MD, the AMBER ff99SBildn (improved side
chain torsion potentials for the Amber ff99SB) forcefield for
the natural residues in the protein and the general AMBER
force field (GAFF) for the glycosylated Asn were used (23, 24).
The Antechamber auxiliary program was used to prepare the
GAFF library of the glycosylated Asn (25). The TIP3P water
model and the AmberTools (26) including a terminal interface
called tLEAP were used to add the ions and the water solvation
box.
Next, all 15OmpAconformationswere docked to the FcRIa
D1 and D2 structure using only the protein-protein complex
pose generation part of ZDOCK (27, 28). The ZDOCK shape
complementarity algorithm generated 54,000 complex poses
with exhaustive rotational and translational sampling for each
configuration of OmpA. Combining this with the 15 separate
docking procedures yielded 810,000 complex poses. We then
eliminated all poses in which FcRIa would have a likely clash
with the virtual membrane where OmpA is buried. This virtual
membrane screening left us 496,100 poses. These poses were
analyzed to determine which glycans and loops are involved in
binding and the number of interprotein salt bridgeswithin each
pose. After eliminating poses that did not agree with the exper-
imental evidence, we obtained 326 poses.
Poses Matching Experimental Input—These 326 hits were
then ranked by their number of interprotein salt bridges, lead-
ing to one pose with amaximum of eight salt bridges. This pose
of OmpA-FcRIa (D1-D2 only) was selected as the structure
likely to have the strongest protein-protein structure that is
consistent with all experimental data. Then the D3 domain of
FcRIa as it is in the crystal structure was added, and the con-
sequent clashes between several loops were resolved by resam-
pling the loop conformations using the DREIDING forcefield,
suggesting that the D2-D3 hinge angle may not be affected
much by the crystal packing as we initially speculated. This new
structure is referred to as OmpA-FcRIa for the remainder of
the manuscript. We then subjected this OmpA-FcRIa struc-
ture to 50 ns of isothermal-isobaric ensemble at 300 K and 1
atm MD simulation in a periodic box with explicit lipid mem-
brane (POPC) and explicit water with 154 mMNaCl, where the
position of OmpA in the membrane is calculated according to
the implicit solvent model of the lipid bilayer in the Orienta-
tions of Proteins inMembranes (OPM) database (29). To allow
the predicted pose to relax any strains that might arise in the
newly formed protein-protein interface from our rigid body
docking procedure, we carried out MD for 50 ns on the full
system including explicit water and ions. We found that all
eight salt bridges and the other polar interactions between the
subunits aremaintained during the 50 ns ofMD, indicating that
the predicted protein-protein complex structure is stable.
Statistical Analysis—All experimental data were derived
from at least three independent experiments. Statistical ana-
lyses were conducted using GraphPad prism online calculator,
and the values are presented asmeans S.D. Significant differ-
ences (p 0.01) between the groupswere determined using the
unpaired Student’s t test.
RESULTS
N-Glycosylation Sites 1, 4, and 5 in the Extracellular Domain
of FcRIa Are Important for E. coli K1 Binding to and Invasion
of RAW 264.7 Macrophages—We previously demonstrated
experimentally that OmpA of E. coli K1 interacts with
GlcNAc1–4GlcNAc epitopes of glycoproteins and that FcRIa
expression is critical for the entry into macrophages (6, 9, 10).
Therefore, we sought to understand the role of NG sites in
FcRIa for E. coli K1 invasion into macrophages. FcRIa con-
tains seven glycosylation sites attached to asparagine residues
as analyzed by the NetNGlyc 1.0 program.Wemutated each of
these to alanines in the FcRIa sequence that contains a Myc
tag. Primers sequences used in themutation of these asparagine
residues are given in Table 1. The change in the amino acid
fromAsn to Ala was verified by nucleotide sequencing. In addi-
tion, loss of one glycosylation site changes the molecular mass
of a glycoprotein by3 kDa. Therefore, the recombinant pro-
teins were subjected to SDS-PAGE and Western blotting with
anti-Myc and anti-FcRIa antibodies. As shown in Fig. 1A, NG
mutants 1–5 of FcRIa migrated lower than wild type FcRIa,
whereas NGmutants 6 and 7 showed similarmolecularmass to
that of wild type protein. This suggests that the consensus NG
sequence sites 6 and 7 identified byNetNGlyc 1.0 programwere
not really glycosylated in FcRIa. Next, the five FcRIa NG
mutants were overexpressed in RAW 264.7 macrophages, and
the expression was verified using anti-Myc antibody by flow
cytometry (Fig. 1B). Transfection efficiency in these cells was
80%, which were then subjected to total cell association and
invasion assays. Total cell associated and intracellular bacteria
were significantly higher with full-length FcRIa (FL-FcRIa),
FcRIa/NG2,/NG3,/NG6, and/NG7. However, overexpression
TABLE 1
Primer sequences used to generate mutations in FcRIa
Forward Reverse
NG1 CAGTGGTTTCTCGCAGGCACAGCCAC GTGGCTGTGCCTGCGAGAAACCACTG
NG2 CTCTGCCAGTGTCGCAGACAGTGGTGAATAC GTATTCACCACTGTCTGCGACACTGGCAGAG
NG3 CCACTGGAATTCTGCCCTCACCATTCTG CAGAATGGTGAGGGCAGAATTCCAGTGG
NG4 CCATTCTGAAAACCGGCATAAGTCACAATGGC GCCATTGTGACTTATGGCGGTTTTCAGAATGG
NG5 CCAACATAAGTCACGCCGGCACCTACCATTG CAATGGTAGGTGCCGGCGTGACTTATGTTGG
NG6 GCTCCAGTGCTGGCAGCATCTGTGAC GTCACAGATGCTGCCAGCACTGGAGC
NG7 CTGCGAGGCAGGGCAACATCCTCTGAATAC GTATTCAGAGGATGTTGCCCTGCCTCGCAG
IgG1 CAGGCATGGGACAGCATCGCTACACATC GATGTGTAGCGATGCTGTCCCATGCCTG
IgG2 GGCATGGGAAAGCATCAGTACACATCAGCAG CTGCTGATGTGTACTGATGCTTTCCCATGCC
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of FcRIa/NG1, FcRIa/NG4, and FcRIa/NG5 showed40%
decrease in the total cell associated and 60% in the invasion of
E. coli K1 compared with FL-FcRIa transfected cells (Fig. 1, C
and D). All these constructs are referred hereafter as FL, NG1,
NG2, NG3, NG4, NG5, NG6, and NG7. The difference in the
invasion in these cells is not due to differences in expression
levels of recombinant FcRIa because flow cytometry of the
transfected cells revealed similar levels of expression.
In addition, we also verified whether the overexpression of
NGmutations alter the Fc-mediated uptake of IgG, FITC-dex-
tran beads coated with IgG were added to RAW 264.7 macro-
phages. After 30 min of incubation, the extracellular fluores-
cence was quenched with Trypan blue, and the cells were then
subjected to flow cytometry to identify the intracellular fluores-
cence for FITC-IgG, as well as Myc tag expression. The data
revealed that NG mutations in FcRIa did alter the Fc-medi-
ated uptake of FITC-beads. In addition, the expression of
FcRIa and its NGmutants was similar in all the transfectants,
indicating thatNGmutations in FcRIa did not alter the phago-
cytic capacity of themacrophages (Fig. 2). These results suggest
that glycosylation sites 1, 4, and 5may play an important role in
FcRIa for E. coli K1 invasion of RAW 264.7 macrophages, and
the invasion process might be independent of Fc-mediated
phagocytosis.
Lack of Specific N-Glycosylation Sites in FcRIa Also Prevents
E. coli K1 Entry into Bone Marrow-derived Macrophages—The
role of NG sites 1, 4, and 5 in FcRIa in the entry of E. coliK1 in
primary macrophages was also examined. BMDMs from mice
were cultured and transfected with various constructs of
FcRIa containing NG mutations and then subjected to total
cell association and invasion assays. Flow cytometry analysis of
transfected BMDMs revealed that Myc expression was similar
in all the transfections (data not shown). Similar to RAW264.7
macrophages, overexpression of NG1, NG4, and NG5 in
BMDMs significantly inhibited both total cell-associated and
intracellular bacteria compared with FL, NG2, NG3, NG6, or
NG7 (Fig. 3, A and B). To examine whether the added bacteria
entered BMDMs transfected with themutant FcRIa plasmids,
scanning and transmission electron microscopy were per-
formed. As shown in Fig. 3C, uninfected BMDMs showed
spread out morphology in S.E., whereas transmission electron
microscopy showed several vacuoles (black arrows) and mito-
chondria (yellow arrows) in the cells. Overexpression of FL
revealed efficient binding of bacteria on the surface of BMDMs,
FIGURE 1. N-Glycosylation sites 1, 4, and 5 in the extracellular domain of FcRIa are important for E. coli K1 binding to and invasion of RAW 264.7
macrophages. A, RAW264.7macrophageswere transfectedwith FL orwith different NGmutants of FcRIawere subjected toWestern blotting analysis using
anti-Myc or anti-FcRIa antibody. Reduction in the size of the bands indicates loss of one NG site. The NGmutation sites in FcRIa are sequentially labeled as
NG1 to NG7. B, the efficiency of plasmid transfection was analyzed concurrently using flow cytometry with the anti-Myc antibody, and the fluorescence
intensity is graphed. The increase in fluorescence intensity in transfected cells was statistically significant compared with untransfected control cells. C andD,
cell association (C) and invasion (D) of E. coli K1 in transfected RAW 264.7 macrophages were performed as described under “Experimental Procedures.”
Decrease in cell association/invasion in FcRIa/NG1,/NG4 and/NG5 transfected RAW 264.7 macrophages was statistically significant. All experiments were
performed at least three times. Cont., control.
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and a number of bacteria entered into the cells as shown in
transmission electron microscopy, which was also observed in
NG3 transfected BMDMs. In contrast, NG1 and NG5 trans-
fected cells had very few bacteria attached to the cell surface,
and those that entered the cells appeared to be subsequently
killed inside vacuoles (black arrows). NG4 transfected BMDMs
also showed results similar to those for NG1 (data not shown).
In addition, FcRIa/ macrophages were also transfected
with FL and mutant FcRIa plasmids and used in E. coli cell
association and invasion assays. FcRIa/ macrophages
inhibited bacterial invasion, evident from a 1.5/2-fold decrease
in cell association/invasion, respectively, when compared with
WT BMDMs, which is consistent with previous data (Fig. 3, D
and E). However, transfection with FL overexpression in these
cells renders them susceptible to E. coli entry. In contrast, over-
expression of NG1, NG4, and NG5 showed lesser intracellular
E. coli comparedwithNG2-, NG3-, NG6-, andNG7-expressing
cells. These results suggest that NG1, NG4, and NG5 play a
significant role in the binding of E. coli to FcRIa and subse-
quent entry into BMDMs but that NG2 and NG3 are not
important.
Adoptive Transfer of FL, but Not NG1-, NG4-, or NG5-trans-
fected BMDMs into FcRIa Knock-out Newborn Mice Restores
the Susceptibility to E. coli K1 Meningitis—We successfully
used adoptive transfer of BMDMs into macrophage-depleted
or FcRIa/ mice and demonstrated that the presence of
macrophages is critical for the onset of meningitis (6). There-
fore, to determine whether NG sites in FcRIa are important
for E. coli K1-induced meningitis in newborn mice, we adop-
tively transferred the BMDMs transfected with FL or NG
FcRIa into 3-day-old FcRIa/ mice and then challenged
withE. coliK1by intranasal instillation on day 3.We conducted
the animal experiments with FL, NG1, NG3, NG4, or NG5 gly-
cosylation mutant FcRIa transfected BMDMs, but only the
data fromNG1,NG3, andNG5 experiments are presented. The
transfected FcRIa/macrophages expressed similar levels of
recombinant proteins on the surface as analyzed by flow cytom-
etry (Fig. 4A). As shown previously, FcRIa/ newborn mice
were resistant to E. coli K1 induced meningitis, whereas adop-
tive transfer of BMDMs transfected with FL or NG3 rendered
the animals susceptible for E. coli K1 infection as measured by
positive cerebrospinal fluid cultures (Fig. 4B). In contrast, adop-
tive transfer of NG1 and NG5 transfected BMDMs still showed
resistance toE. coliK1 infection. In agreementwith the onset of
meningitis, bacteremia levels and brain bacterial load of FL or
NG3 BMDMs transferred mice were significantly higher than
the levels of E. coli K1 in NG1 and NG5 BMDMs transferred
mice (Fig. 4, C and D). Moreover, histological examination of
brain sections of the pups from respective groups was per-
formed using standard H&E, MPO, and GFAP staining. Brains
of newborn mice adoptively transferred with FL or NG3
BMDMs showed loss of tissue integrity, neutrophil infiltration,
and glial cell migration, which are hallmarks of E. coli K1 men-
ingitis, whereas pups transferred with NG1 and NG5 BMDMs
FIGURE 2. Overexpression of FL or NGmutants of FcRIa does not affect IgG uptake in RAW 264.7 macrophages. Untransfected, FL, or NG mutants of
FcRIa transfected RAW264.7macrophages were incubatedwith FITC-IgG for 2 h at 37 °C or incubatedwith trypan blue to quench extracellular fluorescence.
The cells were then incubatedwith anti-Myc antibody followed by Alexa 647 secondary antibody and then subjected to flow cytometry to detect FITC, as well
as Myc expression. Cells were gates (M1) based on fluorescent output from isotype-matched control. A, control. B, full length. C, NG1. D, NG3. E, NG4. F, NG5.
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had intact brain architecture with the absence of neutrophils
and glial cells (Fig. 4E).
Molecular Simulation of OmpA and Glycosylated FcRIa
Interaction Supports the Experimental Results that NG1, NG4,
and NG5 Sites Are Important for Binding—Based on the exper-
imental data that NG sites 1, 4, and 5 in FcRIa are critical to
interacting with OmpA, simulation studies were performed to
unravel molecular bases for this interaction. As described
under “Experimental Procedures,” the FcRIa structure was
assembled initially using D1-D2 domains, and the D3 domain
was added finally by resolving loop clashes (Fig. 5A). The ori-
entation of NG sites 1–5 obtained from the centroid conforma-
tion of 5-ns MD trajectory is shown in Fig. 5B. The modeling
predicted a large number (810,000) of docking poses for the
protein-protein complex, which was done with no inclusion of
experimental data. These structures were then analyzed on the
basis of the experiments to obtain 326 poses. One pose had
eight salt bridges, whereas four poses that had seven salt bridges
were identified, and all others had fewer. Four of these five
structures were similar, and we chose the one with eight salt
bridges to examine in detail. The resulting three-dimensional
structure supports interpretations of the experiments that
N-glycan sites 1, 4, and 5 interact with OmpA. The transmem-
brane region of OmpAwas then embedded in the POPCmem-
brane with the rest of the complex and solvated in water. Then
protein-protein complex was then subjected to 50 ns of MD
FIGURE 3. Lack of specific N-glycosylation sites in FcRIa also prevents entry into bonemarrow-derivedmacrophages. A and B, bone marrow-derived
macrophages from C57BL/6 mice (WT BMDMs) were transfected with FL or NGmutants of FcRIa and subjected to cell association (A) and invasion (B) assays.
C, scanning and transmission electron microscopy analysis of WT BMDMs transfected with FL or NG1, NG3, and NG5 mutants of FcRIa. D and E, FcRIa/
BMDMs were transfected with FL or NG mutants and subjected to cell association (D) and invasion (E) assays. Untransfected FcRIa/ BMDMs and BMDMs
from C57BL/6 mice served as controls. The cell association/invasion assays were performed at least three times, and the increase (*) or decrease (#) in cell
association/invasion patterns was statistically significant (p 0.05). Arrowheads, bacteria; black arrows, vacuoles or mitochondria. Cont., control.
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FIGURE 4. Adoptive transfer of FL and NG3, but not NG1- or NG5-transfected FcRIa/ BMDMs into FcRIa/ newbornmice restores the suscepti-
bility to E. coli K1 meningitis. A, transfection efficiency of plasmids in FcRIa/ BMDMs was confirmed by flow cytometry using anti-Myc tag antibody.
FcRIa/ newborn mice (n  5) were adoptively transferred with FcRIa/ BMDMs containing different plasmid constructs at 66 h after birth and then
infected intranasallywith103E. coliK1at 72h.B, all fivepups carryingFLorNG3 transfectedBMDMshadE. coliK1-positive cerebrospinal fluid (CSF) cultures 72h
postinfection. C, bacterial load in blood at 48 and 72 h postinfection from each pup was collected and plated on LB rifampicin to enumerate bacteremia
levels.D, homogenates from half of the brain from all pupswere plated on LB rifampicin after euthanatizing them 72 h postinfection. E, the other half of the
brain was preserved in formalin, embedded in paraffin, sectioned, and stained for brain pathology (H&E), GFAP, and neutrophil infiltration (MPO). Arrows
represent neuronal loss in H&E stained sections or glial cells in GFAP-stained sections. Neutrophil infiltration is represented by arrowheads in H&E-stained
sections and arrows in MPO-stained sections. Cont., control.
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FIGURE 5.ModelingofN-glycosylated FcRIa andOmpA interaction shows thatNG1,NG4, andNG5bind to loop andbarrel sites ofOmpA.A,N-glycan
precursors (Man-GlcNAc-GlcNAc) are added to the five N-glycosylation sites in D1 and D2 domains of the FcRIa crystal structure. Glycan conformations are
taken from the centroid conformation of 5ns MD trajectory. B, glycans 1, 4 and 5 (shown as silver sticks) of D1 and D2 of FcRIa (cyan) are involved in binding
OmpA (green). Glycan 5 sticks into the -barrel mouth of OmpA and forms salt bridges in all corners with FcRIa, stabilizing the protein-protein interface.
Positively charged residues are represented as blue spheres, whereas negatively charged residues are shown as red spheres. The IgG-binding loop of FcRIa
(orange) is not involved in binding OmpA. C, glycans 1 forms a hydrogen bondwith Asp-149 of OmpA and is in proximity to Asn-146 and Arg-156 of OmpA to
formwatermediated hydrogen bonds. Glycan 5 is in the barrel binding pocket between loops 3 and 4 of OmpA and forms direct noncovalent interactionwith
Trp-102, Ser-120, Ala-150, His-151, Thr-155, and Pro-157 of OmpA. Glycan 5 could also formwater-mediated interactionwith Asp-116, Thr-106, and Lys-107 of
OmpA. Glycan 2 is too far away fromOmpAanddoes not have any possibility to formdirect or indirect interactionwithOmpA.D, NG4 does not form any direct
noncovalent interactions with OmpA but is in proximity to OmpA to form indirect interaction like water-mediated hydrogen bonds. E, rotating the torsional
angles1 and2 of Asn-159 in FcRIa by 79 ° and45 °, respectively, replaces thehydrogenbondbetweenglycan4 (silver conformation) andSer-161of FcRIa
(colored cyan) by anewhydrogenbondbetweenglycan4 (salmon conformation) and Ile-160of FcRIa,while also forming twomorenewhydrogenbonds that
contribute to the direct interaction between glycan 4 and Asn-109 in loop 3 of OmpA (colored green).
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simulation. The 50-ns MD trajectory on the OmpA-FcRIa
complex led to stable and reasonable interactions for the five
important salt bridges, each of which remained stable during 50
ns of MD (Fig. 5B). In addition to many new water-mediated
hydrogen bonds showing up in theMD,we found thatNG1 and
NG5 formed direct noncovalent interactions with OmpA (Fig.
5C). It should be noted here that the waters in the x-ray struc-
ture were removed before doing the protein-protein docking to
allow the protein side chains full freedom to interact with the
other protein and prevent water-mediated effects on side
chains thatmight interfere with the docking. Some of the inter-
nal waters from ourMDmight not find the same positions as in
the x-ray. Although NG4 is close to OmpA, the 50-ns MD sim-
ulation of OmpA-FcRIa did not lead to any direct interaction
between the glycan of NG4 and OmpA (Fig. 5D). Instead, the
predicted NG4 conformation was locked into a hydrogen bond
within FcRIa between the side chain carbonyl group of Asn-
159 and the backbone amino group of Ser-161. This hydrogen
bond remained stable during 50 ns of MD trajectory. This lack
of interaction of NG4 with OmpA was inconsistent with the
experimental data because a lack of NG4 also prevented the
bacterial invasion into macrophages. However, we speculated
that the strong interaction with Asn-159 and Ser-161 might be
accidental, caused by our initial configuration. To test this, we
rotated the side chain torsional angles of Asn-159 (the 1 angle
from 66 to 145 ° and the 2 angle from 75 to 30 °) to form direct
interactions between NG4 and OmpA. This caused the hydro-
gen bond between Asn-159/Ser-161 to break, forming instead
three new hydrogen bonds (one between carbonyl of Asn-159
side chain and backbone amino group of Ile-160 within FcRIa
and another two between the second GlcNAc moiety in NG4
and Asn-109 on loop 3 of OmpA). This new conformation of
NG4 does not clash with any of the protein-protein interfacial
peptides. We carried out 50 ns of simulation with this new
structure and found it to be stable (Fig. 5E).
The NG5 binding site in the barrel between loops 3 and 4 of
OmpA predicted here coincides with the barrel binding site of
GlcNAc1–4GlcNAc (chitobiose) epitopes predicted in our pre-
vious work, in which we docked small ligand GlcNAc1-
4GlcNAc (chitobiose) to OmpA (9). To test how sensitive this
barrel binding site is to the sugar unit when attached to the
protein, we added the common N-glycan core sugar sequence
Man1–4GlcNAc1–4GlcNAc1 to D1 and D2 domains of
FcRIa. In this predicted binding mode of the three-sugar unit
Man1-GlcNAc2 at the NG5 site, the two GlcNAc moieties
maintain their interaction with OmpA as in GlcNAc1-
4GlcNAc binding mode (Fig. 5C). Subsequently, theD3 domain
and Man1–6(Man1–3)-Man1–4GlcNAc1–4GlcNAc1
were also included in the minimization, which did not change
the interaction of GlcNAc1–4GlcNAc with the OmpA (data
not shown). This suggests that mannoses play a less important
role than GlcNAc epitopes in N-glycan binding to OmpA.
These data are consistent with the previous experimental
observations in which removal of mannose residues from
N-glycosylation sites using differentmannosidases did not alter
the binding of E. coli to endothelial cells (10). Taken together,
the simulation studies support the experimental evidence that
NG1,NG4, andNG5 interactwith loops 1, 3, and 4 ofOmpA for
binding, and provide a detailed three-dimensional structure
that can be used to better understand the nature of the protein-
protein complex, which will help in developing molecules that
might block formation of this complex and hence prevent neo-
natal meningitis.
Mutation of Fc-binding Region in FcRIa Did Not Affect the
E. coli Binding to or Entry in Macrophages—The crystal struc-
ture of the N-terminal region of FcRIa was reported recently
(22). We note that the NG sites 1, 2, and 3 are upstream of the
Fc-binding region, whereas the other NG sites were down-
stream of it (Fig. 5A). Our previous experimental studies
showed that OmpA E. coli, but not OmpA E. coli, was able
to displace FcRIa-bound IgG in RAW 264.7 macrophages (6).
However, it was unclear whether OmpA displaced IgG by com-
petitive binding to the Fc-binding site or by an allosteric effect
in which OmpA binds to a different region on FcRIa. Because
the Fc-binding region was strategically placed between active
binding sites of E. coliK1OmpA,we next experimentally ascer-
tained the role of IgG-binding site (sequence MGKHRY) of
FcRIa in OmpA binding. To do this, we performed site-di-
rectedmutagenesis at two residues, a lysine to glutamine and an
arginine to glutamine. Briefly, MGKHRY was mutated to
MGQHRY (IgG1) and MGKHQY (IgG2) in FL-FcRIa-Myc
plasmid. RAW 264.7 macrophages were transfected with
mutated IgG1 or IgG2 plasmids, expression efficiency was ver-
ified byMyc expression using flow cytometry (Fig. 6A), and the
macrophages were subsequently subjected to total cell-associ-
ated and invasion assays. We found that E. coli K1 bound and
invaded IgG1 and IgG2 transfected RAW 264. 7 macrophages
at the same frequency as that of FL, implying that mutation of
critical residues in Fc-binding region did not alter bacterial
binding and invasion (Fig. 6,B andC).We also observed similar
results when FcRIa/ BMDMs were transfected with IgG1
and IgG2plasmids (Fig. 6D). This led us to conclude thatOmpA
does not bind directly to the Fc region and that OmpA may
displace IgG by binding to flanking NG1, 4, and 5 sites.
Adoptive Transfer of IgG1 and IgG2Transfected BMDMs into
FcRIa/ Newborn Mice Also Restores the Susceptibility to
E. coli Meningitis—To confirm the insignificant role of IgG
mutations in the onset of meningitis in the newborn mouse
model, we performed adoptive transfer experiments using
BMDMs transfected with FL, IgG1, and IgG2 in 3-day-old
FcRIa/ pups. Prior to adoptively transferring the BMDMs
into newborn mice, the transfected cells were subjected to
FITC-IgG uptake assay by flow cytometry. As shown in Fig. 6E,
both mutations in the IgG region significantly prevented the
entry of FITC-IgG compared with FL transfected cells despite
the fact that the expression levels of the mutant proteins were
similar as determined with anti-Myc antibody staining. After
adoptive transfer into 3-day-oldmice, these BMDMs (IgG1 and
IgG2 transfected cells) restored the susceptibility of newborn
pups similar to FL transfected cells to E. coli K1. Bacteremia
levels, brain bacterial load, and cerebrospinal fluid positive cul-
tures in IgG1 and IgG2 were of the same magnitude as
FL-FcRIa, reiterating our in vitro and ex vivo observations that
Fc-binding region of FcRIa does not play a role in E. coli K1
binding and invasion of macrophages. Similarly, histological
examination of brain sections of the pups transferredwith IgG1
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FIGURE 6.Adoptive transfer of BMDMs transfectedwith IgG1 and IgG2mutants of FcRIa into FcRIa/newbornmice restores the susceptibility to
E. colimeningitis.A, transfectionefficiencyof FL, IgG1, and IgG2plasmids in FcRIa/BMDMswas confirmedby flowcytometry usinganti-Myc tagantibody.
B–D, cell association and invasion assays of E. coli K1were performed in RAW264.7macrophages (B), WT BMDMs (C), or FcRIa/ BMDMs (D) transfectedwith
FL, IgG1, or IgG2. The increase in cell association and/or invasion was statistically significant. E, FL, IgG1, or IgG2 transfected RAW 264.7 macrophages were
incubatedwith IgG-FITC for 2 h at 37 °C, incubatedwith trypan blue to quench extracellular fluorescence and then subjected to flow cytometry to detect FITC,
as well as Myc expression using anti-Myc antibody and Alexa 647 secondary antibody. Cells were gated (M1) based on fluorescent output from isotype-
matched control. F, brain sections of FcRIa/ pups that were adoptively transferred with FcRIa/ BMDMs carrying FL, IgG1, or IgG2 plasmids and then
infectedwithE. coliK1were subjected toH&E,GFAP, andMPOstainingasdescribedpreviously.Yellowarrows representneutrophil infiltration, andblackarrows
represent neuronal apoptosis in H&E-stained sections. Arrows in GFAP or MPO stained sections show the accumulation of glial cells or neutrophils.
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and IgG2 showed loss of tissue integrity, neutrophil infiltration,
and glial cell migration, similar to FL transferred pups (Fig. 6F;
only IgG1 data shown). These results clearly show that the Fc-
binding region in FcRIa is not critical for E. coli K1-induced
onset of meningitis in newborn mice.
DISCUSSION
This study demonstrates three important pieces of evidence
to confirm that E. coli K1 OmpA interaction with FcRIa in
macrophages is critical for the onset of meningitis in newborn
mice: First, we showed clearly that threeN-glycans (NG1, NG4,
and NG5) present in the extracellular domains of FcRIa inter-
act withOmpA for binding to and invasion ofmacrophages and
that there is no role for IgG binding region in this interaction.
Second, lack of these NG sites in FcRIa of macrophages that
were adoptively transferred into newborn FcRIa/mice ren-
ders the animals resistant to E. coli K1-induced meningitis.
Third, computer simulation studies of OmpA interacting with
N-glycans added to FcRIa show that OmpA interacts with the
NG sites of FcRIa for binding.
This mechanism of direct binding of OmpA to FcRIa NG
sites is quite contrary to the mechanisms used by several other
bacteria, which utilize a “Trojan horse”mechanism to enter the
central nervous system (30). S. aureus avoids macrophage rec-
ognition by binding to IgG via protein A, whereas other
microbes manipulate macrophage activity by secreting effector
proteins (1, 4). Thus, OmpA interaction with FcRIa via the
three extracellular N-glycans represents a novel phenomenon
in E. coli K1-induced neonatal meningitis.
Although OmpA is conserved throughout evolution, recent
studies have identified that the ompA gene exists in two allelic
forms, ompA1 and ompA2. Specific subsets of OmpA may be
more or less invasive depending on the sequence of loop 2 of
OmpA (31). In analyzing the roles of these loops in the patho-
genesis of neonatal meningitis, we observed that loops 1 and 2
are critical for the onset of the disease in newborn mouse
model. However, loops 1 and 3 are shown to be necessary for
the invasion of E. coli K1 into cultured macrophages, whereas
loops 1 and 2 are critical to cross the blood-brain barrier (8).
Our current results suggest that mutation of NG sites 1, 4, and
5 show a significantly greater reduction in the invasion of E. coli
K1 into macrophages compared with other mutations. Taken
together, these results suggest that OmpA uses its four flexible
loops to interact with N-glycans of FcRIa in macrophages or
gp96 in brain endothelial cells.
Our experimental observations were utilized in the compu-
tational protein-protein docking-based protocol to predict an
all-atomprotein-protein complex structure that explains all the
experimental results in terms of the interactions at the atomic
level, revealing where the three N-glycan binding sites are in
OmpA. The overlap between two of these threeN-glycan bind-
ing sites with the previously predicted two chitobiose binding
sites by a completely different computational method suggests
that OmpA may use these specific loop and barrel sites to rec-
ognize the carbohydrate moieties in the glycosylated proteins.
Our model is that, after OmpA brings the protein target closer
through binding the glycans that extend out from the target
protein surface, it then forms salt bridges and hydrogen bonds
with the target protein to stabilize the protein-protein inter-
face. In addition, our previous results demonstrated that E. coli
K1 binding to FcRIa displaces bound IgG to macrophages,
indicating that OmpA may also interact or form salt bridges
with IgG binding regions. However, the current study on the
mutations in IgG binding sites in FcRIa show that this region
plays no role in the invasion of E. coli K1 in macrophages. This
was predicted by the computed structure of the complex prior
to the mutation experiments. Additional studies will be needed
to examine whether the peptide regions of FcRIa interacting
with OmpA, which are not involved in binding IgG, play any
role in altering the signaling mechanisms induced by FcRIa.
Recent developments in the application of dynamics and
simulation have helped unravel temporal progress of bacterial-
host interactions. Simulation studies have identified novel
mechanisms of “molecular mimicry” by pathogens that modify
their virulence factors to resemble host ligands on receptors
(32). Moreover, simulation of receptor N-glycosylation has
strengthened our understanding of host cell manipulation by
parasites such as Trypanosoma brucei (11). However, little
information is available on the interaction of bacterial virulence
factors with N-glycosylated host receptors. Indeed, molecular
simulation studies of an N-glycosylated protein with a protein
ligand had not been attempted previously. Thus, our study
introduces a novel method of integrating molecular modeling
and experimental evidence to predict the protein-protein inter-
face of OmpA with glycosylated FcRIa. This predicted struc-
ture presents an atomistic detail of the interactions that provide
amechanistic understanding of one aspect of the bacterial inva-
sion process in neonatal meningitis. It can also be used to for-
mulate further experimental and computational tests to obtain
deeper understanding of the interactions of OmpA with the
peptide regions of FcRIa beyond the glycosylation portions.
Thiswould provide the basis for structure-based design of small
molecule inhibitors to prevent E. coli K1 interaction with
FcRIa, thereby preventing the bacterial multiplication in
macrophages.
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